CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 72 filers reported holding CARDIFF ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214 | -53.3% | 154,000 | -50.5% | 0.00% | -100.0% |
| Q2 2023 | $458 | -16.3% | 311,290 | -6.0% | 0.00% | 0.0% |
| Q1 2023 | $547 | -20.4% | 331,308 | -32.5% | 0.00% | 0.0% |
| Q4 2022 | $687 | -99.9% | 490,990 | +16.4% | 0.00% | 0.0% |
| Q3 2022 | $650,000 | -59.4% | 421,988 | -42.0% | 0.00% | -50.0% |
| Q2 2022 | $1,601,000 | +31.3% | 727,616 | +48.1% | 0.00% | +100.0% |
| Q1 2022 | $1,219,000 | -9.5% | 491,458 | +82.8% | 0.00% | 0.0% |
| Q2 2020 | $1,347,000 | – | 268,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |